BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24424385)

  • 1. Validation of the mid-position strategy for lung tumors in helical TomoTherapy.
    Wanet M; Sterpin E; Janssens G; Delor A; Lee JA; Geets X
    Radiother Oncol; 2014 Mar; 110(3):529-37. PubMed ID: 24424385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric Benefits of Midposition Compared With Internal Target Volume Strategy for Esophageal Cancer Radiation Therapy.
    Jin P; Machiels M; Crama KF; Visser J; van Wieringen N; Bel A; Hulshof MCCM; Alderliesten T
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):491-502. PubMed ID: 30253234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helical tomotherapy for SIB and hypo-fractionated treatments in lung carcinomas: a 4D Monte Carlo treatment planning study.
    Sterpin E; Janssens G; Orban de Xivry J; Goossens S; Wanet M; Lee JA; Delor A; Bol V; Vynckier S; Gregoire V; Geets X
    Radiother Oncol; 2012 Aug; 104(2):173-80. PubMed ID: 22841518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technical Note: Treatment planning system (TPS) approximations matter - comparing intensity-modulated proton therapy (IMPT) plan quality and robustness between a commercial and an in-house developed TPS for nonsmall cell lung cancer (NSCLC).
    Liu C; Yu NY; Shan J; Bhangoo RS; Daniels TB; Chiang JS; Ding X; Lara P; Patrick CL; Archuleta JP; DeWees T; Hu Y; Schild SE; Bues M; Sio TT; Liu W
    Med Phys; 2019 Nov; 46(11):4755-4762. PubMed ID: 31498885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITV versus mid-ventilation for treatment planning in lung SBRT: a comparison of target coverage and PTV adequacy by using in-treatment 4D cone beam CT.
    Bellec J; Arab-Ceschia F; Castelli J; Lafond C; Chajon E
    Radiat Oncol; 2020 Mar; 15(1):54. PubMed ID: 32127010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage.
    Wang L; Hayes S; Paskalev K; Jin L; Buyyounouski MK; Ma CC; Feigenberg S
    Radiother Oncol; 2009 Jun; 91(3):314-24. PubMed ID: 19111362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment planning and 4D robust evaluation strategy for proton therapy of lung tumors with large motion amplitude.
    Taasti VT; Hattu D; Vaassen F; Canters R; Velders M; Mannens J; van Loon J; Rinaldi I; Unipan M; van Elmpt W
    Med Phys; 2021 Aug; 48(8):4425-4437. PubMed ID: 34214201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-position treatment strategy for locally advanced lung cancer: a dosimetric study.
    Ayadi M; Baudier T; Bouilhol G; Dupuis P; Boissard P; Pinho R; Krason A; Rit S; Claude L; Sarrut D
    Br J Radiol; 2020 Jun; 93(1110):20190692. PubMed ID: 32293191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of PTV dose coverage on cancer control outcomes in early stage non-small cell lung cancer patients treated with highly ablative stereotactic body radiation therapy.
    Shaverdian N; Tenn S; Veruttipong D; Wang J; Hegde J; Lee C; Cao M; Agazaryan N; Steinberg M; Kupelian P; Lee P
    Br J Radiol; 2016; 89(1059):20150963. PubMed ID: 26764282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional versus four-dimensional dose calculation for volumetric modulated arc therapy of hypofractionated treatments.
    Ehrbar S; Lang S; Stieb S; Riesterer O; Stark LS; Guckenberger M; Klöck S
    Z Med Phys; 2016 Mar; 26(1):45-53. PubMed ID: 26187810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose calculations accounting for breathing motion in stereotactic lung radiotherapy based on 4D-CT and the internal target volume.
    Admiraal MA; Schuring D; Hurkmans CW
    Radiother Oncol; 2008 Jan; 86(1):55-60. PubMed ID: 18082905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of planned dose on different CT image sets to four-dimensional Monte Carlo dose recalculation using the patient's actual breathing trace for lung stereotactic body radiation therapy.
    Freislederer P; von Münchow A; Kamp F; Heinz C; Gerum S; Corradini S; Söhn M; Reiner M; Roeder F; Floca R; Alber M; Belka C; Parodi K
    Med Phys; 2019 Jul; 46(7):3268-3277. PubMed ID: 31074510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of a TPS-integrated method to incorporate tumor motion in the margin recipe.
    Dechambre D; Vander Veken L; Delor A; Sterpin E; Vanneste F; Geets X
    Med Dosim; 2021 Autumn; 46(3):253-258. PubMed ID: 33685768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of interfractional variation of the centroid position and volume of internal target volume during stereotactic body radiotherapy of lung cancer using cone-beam computed tomography.
    Sun Y; Ge H; Cheng S; Yang C; Zhu Q; Li D; Tian Y
    J Appl Clin Med Phys; 2016 Mar; 17(2):461-472. PubMed ID: 27074466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
    Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of simple IMRT delivery techniques for non-small cell lung cancer patients with respiratory motion using 4DCT.
    Reitz B; Parda DS; Colonias A; Lee V; Miften M
    Med Dosim; 2009; 34(2):158-69. PubMed ID: 19410146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative accuracy of 4D dose accumulation for lung radiotherapy using rigid dose projection versus dose recalculation on every breathing phase.
    Valdes G; Lee C; Tenn S; Lee P; Robinson C; Iwamoto K; Low D; Lamb JM
    Med Phys; 2017 Mar; 44(3):1120-1127. PubMed ID: 28019649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations.
    Flampouri S; Jiang SB; Sharp GC; Wolfgang J; Patel AA; Choi NC
    Phys Med Biol; 2006 Jun; 51(11):2763-79. PubMed ID: 16723765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Megavoltage conebeam CT cine as final verification of treatment plan in lung stereotactic body radiotherapy.
    Kudithipudi V; Gayou O; Colonias A
    J Med Imaging Radiat Oncol; 2016 Jun; 60(3):441-5. PubMed ID: 26850083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.